FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share healthy steps to reverse the condition.

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...